Main Article Content
Background: Jaundice is a condition that makes the skin, body tissues and fluids yellowish in color. You often see the color on the skin or the white parts of the eyes. The yellow color is caused by the accumulation of bilirubin in the blood. Bilirubin is a pigment that leaks into the blood when red blood cells break down. This study aimed to identify jaundice and its relationship to the occurrence of jaundice in newborns with blood groups and its relationship to anemia, to study jaundice, to reveal its causes and what are the methods of diagnosis and treatment methods in all respects, and to clarify the extent of its spread. To the effect of jaundice on the health of the newborn and to know whether the effect of jaundice persists for advanced periods of the patient’s life, the study reached a number of conclusions, the most important of which are: Anemia, yellowing of the skin and eyes, and an enlarged spleen are the symptoms of jaundice, a hereditary condition brought on by a genetic defect in the membrane of red blood cells. The red cells in hemolytic jaundice are less elastic, rounder, and more fragile than normal red cells. Red blood cells frequently become caught in constrictive blood vessels, such as the spleen, which causes them to degrade and result in anemia. An enlarged spleen results from red cell blockage of the spleen. This occurs when red blood cells release their hemoglobin. The heme fraction then produces bilirubin, and too much bilirubin causes gallstones to develop even in young children. Iron-rich red blood cells are also destroyed by excess iron.
This work is licensed under a Creative Commons Attribution 4.0 International License.
- • Bratlid, D., Nakstad, B., & Hansen, T. W. R. (2011). National guidelines for treatment of jaundice in the newborn. Acta Paediatrica, 100(4), 499–505.
- • Bujandric, N., & Grujic, J. (2016). Exchange transfusion for severe neonatal hyperbilirubinemia: 17 years’ experience from Vojvodina, Serbia. Indian Journal of Hematology and Blood Transfusion, 32(2), 208–214.
- • Cappellini, M. D., Musallam, K. M., & Taher, A. T. (2020). Iron deficiency anaemia revisited. Journal of Internal Medicine, 287(2), 153–170.
- • Gartner, L. M., & Lee, K. (1999). Jaundice in the breastfed infant. Clinics in Perinatology, 26(2), 431–445.
- • He, Y., Jia, S., Dewan, R. K., & Liao, N. (2017). Novel mutations in patients with hereditary red blood cell membrane disorders using next-generation sequencing. Gene, 627, 556–562.
- • Jahanshahifard, S., Ahmadpour-Kacho, M., & Pasha, Y. Z. (2012). Effects of phototherapy on cytokines’ levels and white blood cells in term neonate with hyperbilirubinemia. Journal of Clinical Neonatology, 1(3), 139.
- • Mariakakis, A., Banks, M. A., Phillipi, L., Yu, L., Taylor, J., & Patel, S. N. (2017). Biliscreen: smartphone-based scleral jaundice monitoring for liver and pancreatic disorders. Proceedings of the ACM on Interactive, Mobile, Wearable and Ubiquitous Technologies, 1(2), 1–26.
- • Mishra, S., Agarwal, R., Deorari, A. K., & Paul, V. K. (2008). Jaundice in the newborns. The Indian Journal of Pediatrics, 75(2), 157–163.
- • Neufeld, L. M., Larson, L. M., Kurpad, A., Mburu, S., Martorell, R., & Brown, K. H. (2019). Hemoglobin concentration and anemia diagnosis in venous and capillary blood: biological basis and policy implications. Annals of the New York Academy of Sciences, 1450(1), 172–189.
- • Omekwe, D. E., George, M. D., Kennis, B. T., Fakuma, B. N., Evdence, C. C., Destiny, E. F., Seimiekumo, F. E., & Owoeye, G. I. O. (2014). Survey and management outcome of neonatal jaundice from a developing tertiary health centre, Southern Nigeria. IOSR Journal of Dental and Medical Sciences, 13(4), 35–39.
- • Outlaw, F., Nixon, M., Odeyemi, O., MacDonald, L. W., Meek, J., & Leung, T. S. (2020). Smartphone screening for neonatal jaundice via ambient-subtracted sclera chromaticity. PloS One, 15(3), e0216970.
- • Rao, R., & Georgieff, M. K. (2007). Iron in fetal and neonatal nutrition. Seminars in Fetal and Neonatal Medicine, 12(1), 54–63.